These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35303953)

  • 1. Cost-effectiveness analysis on COVID-19 surveillance strategy of large-scale sports competition.
    Wang X; Cai Y; Zhang B; Zhang X; Wang L; Yan X; Zhao M; Zhang Y; Jia Z
    Infect Dis Poverty; 2022 Mar; 11(1):32. PubMed ID: 35303953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
    Reddy KP; Shebl FM; Foote JHA; Harling G; Scott JA; Panella C; Fitzmaurice KP; Flanagan C; Hyle EP; Neilan AM; Mohareb AM; Bekker LG; Lessells RJ; Ciaranello AL; Wood R; Losina E; Freedberg KA; Kazemian P; Siedner MJ
    Lancet Glob Health; 2021 Feb; 9(2):e120-e129. PubMed ID: 33188729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Risk Assessment for the Tokyo Olympic Games.
    Zhu W; Feng J; Li C; Wang H; Zhong Y; Zhou L; Zhang X; Zhang T
    Front Public Health; 2021; 9():730611. PubMed ID: 34760863
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimization of COVID-19 prevention and control measures during the Beijing 2022 Winter Olympics: a model-based study.
    Kong L; Duan M; Shi J; Hong J; Zhou X; Yang X; Zhao Z; Huang J; Chen X; Yin Y; Li K; Liu Y; Liu J; Wang X; Zhang P; Xie X; Li F; Chang Z; Zhang Z
    Infect Dis Poverty; 2022 Sep; 11(1):95. PubMed ID: 36068625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and cost-effectiveness of malaria reactive case detection using loop-mediated isothermal amplification compared to microscopy in the low transmission setting of Aceh Province, Indonesia.
    Zelman BW; Baral R; Zarlinda I; Coutrier FN; Sanders KC; Cotter C; Herdiana H; Greenhouse B; Shretta R; Gosling RD; Hsiang MS
    Malar J; 2018 Jun; 17(1):220. PubMed ID: 29859081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.
    Paltiel AD; Zheng A; Walensky RP
    JAMA Netw Open; 2020 Jul; 3(7):e2016818. PubMed ID: 32735339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis.
    Neilan AM; Cohn J; Sacks E; Gandhi AR; Fassinou P; Walensky RP; Kouadio MN; Freedberg KA; Ciaranello AL
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab225. PubMed ID: 34189169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; de Wit GA; Bonsel GJ; van Hout BA
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey.
    Hagens A; İnkaya AÇ; Yildirak K; Sancar M; van der Schans J; Acar Sancar A; Ünal S; Postma M; Yeğenoğlu S
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33919586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.
    Smith DRM; Duval A; Pouwels KB; Guillemot D; Fernandes J; Huynh BT; Temime L; Opatowski L;
    BMC Med; 2020 Dec; 18(1):386. PubMed ID: 33287821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and Cost-Effectiveness of a Telehealth Service at a Centralized COVID-19 Quarantine Center in Taiwan: Cohort Study.
    Yen YF; Tsai YF; Su VY; Chan SY; Yu WR; Ho H; Hou CM; Chen CC; Woung LC; Huang SJ
    J Med Internet Res; 2020 Dec; 22(12):e22703. PubMed ID: 33259324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Public Health Measures to Control COVID-19 in China: A Microsimulation Modeling Study.
    Wang Q; Shi N; Huang J; Yang L; Cui T; Ai J; Ji H; Xu K; Ahmad T; Bao C; Jin H
    Front Public Health; 2021; 9():726690. PubMed ID: 35059369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
    Zhu D; Lv M; Bai Y; Wu J; He P
    Vaccine; 2022 Feb; 40(7):994-1000. PubMed ID: 35065820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing.
    Johansson MA; Wolford H; Paul P; Diaz PS; Chen TH; Brown CM; Cetron MS; Alvarado-Ramy F
    BMC Med; 2021 Apr; 19(1):94. PubMed ID: 33849546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.
    Pandor A; Thokala P; Gomersall T; Baalbaki H; Stevens JW; Wang J; Wong R; Brennan A; Fitzgerald P
    Health Technol Assess; 2013 Aug; 17(32):1-207, v-vi. PubMed ID: 23927840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia.
    Olsen M; Norheim OF; Memirie ST
    Int J Equity Health; 2021 Jan; 20(1):9. PubMed ID: 33407559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control.
    Cirera L; Galatas B; Alonso S; Paaijmans K; Mamuquele M; Martí-Soler H; Guinovart C; Munguambe H; Luis F; Nhantumbo H; Montañà J; Bassat Q; Candrinho B; Rabinovich R; Macete E; Aide P; Alonso P; Saúte F; Sicuri E
    PLoS One; 2020; 15(7):e0235631. PubMed ID: 32628741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.